Henning Helmke

Corporate Officer/Principal presso Göhmann Rechtsanwälte Partnergesellschaft

Consumer Services

Health Technology

Profilo

Henning Helmke is currently a Member at Göhmann Rechtsanwälte Partnergesellschaft.
He previously worked as a Director-Supervisory Board at KeyNeurotek Pharmaceuticals AG.
Mr. Helmke has a graduate degree from the University of Gottingen and undergraduate degrees from Eberhard Karls Universität Tübingen, the University of Geneva, and Université Paris 8 Vincennes Saint-Denis.

Posizioni attive di Henning Helmke

Società	Posizione	Inizio
Göhmann Rechtsanwälte Partnergesellschaft	Corporate Officer/Principal	14/05/2010

Tutte le posizioni attive di Henning Helmke

Precedenti posizioni note di Henning Helmke

Società	Posizione	Fine
KeyNeurotek Pharmaceuticals AG KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany.	Direttore/Membro del Consiglio	03/08/2011

Vedi nel dettaglio l'esperienza di Henning Helmke

Formazione di Henning Helmke

Eberhard Karls Universität Tübingen	Undergraduate Degree
University of Geneva	Undergraduate Degree
Université Paris 8 Vincennes Saint-Denis	Undergraduate Degree
University of Gottingen	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Henning Helmke

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
KeyNeurotek Pharmaceuticals AG KeyNeurotek Pharmaceuticals AG Pharmaceuticals: OtherHealth Technology KeyNeurotek Pharmaceuticals AG is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal and autoimmune diseases. KeyNeurotek’s drug portfolio covers the entire drug development chain from research stage to advanced clinical development. At present, two compounds are in clinical development, KN38-7271 and KN203, both addressing significant markets such as traumatic brain injury, TBI, stroke, and urinary incontinence/overactive bladder. The company’s product development is based on its proprietary technology platform, which has been specifically tailored to diseases of the central nervous system, TELOMICS. KeyNeurotek was founded by Dr Frank Striggow, Frank Baumgart, Prof Dr Klaus G. Reymann and Prof Dr Henning Scheich in May 2000. The company is located in Magdeburg, Germany.	Health Technology
Göhmann Rechtsanwälte Partnergesellschaft